Cardiol Therapeutics Inc (CRDL) COM NPV CL A

Sell:1.70 CADBuy:1.73 CADNo change

Prices delayed by at least 15 minutes
Sell:1.70 CAD
Buy:1.73 CAD
Change:No change
Prices delayed by at least 15 minutes
Sell:1.70 CAD
Buy:1.73 CAD
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Cardiol Therapeutics Inc. is a Canada-based clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead small-molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It holds investigational new drug application authorization from the United States Food and Drug Administration (US FDA) to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart: recurrent pericarditis and acute myocarditis. The MAVERIC Program in recurrent pericarditis, an inflammatory disease, comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing Phase III MAVERIC trial (NCT06708299). The Company is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure.

Key people

David Elsley
President, Chief Executive Officer, Director
Christopher Waddick
Chief Financial Officer, Corporate Secretary, Director
Bernard Lim
Chief Operating Officer
Andrew Hamer
Chief Medical Officer, Head of Research and Development
Guillermo Torre-Amione
Independent Chairman of the Board
Timothy Garnett
Director
Jennifer M. Chao
Independent Director
Teri Loxam
Independent Director
Peter Pekos
Independent Director
Click to see more

Key facts

  • EPIC
    CRDL
  • Location
    Canada
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CA14161Y2006
  • Market cap
    CA$145.64m
  • Employees
    18
  • Shares in issue
    82.61m
  • Exchange
    Toronto Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.